Select Medical (SEM)
(Delayed Data from NYSE)
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$33.70 USD
+0.56 (1.69%)
Updated Oct 11, 2024 04:00 PM ET
After-Market: $33.68 -0.02 (-0.06%) 7:58 PM ET
5-Strong Sell of 5 5
B Value A Growth B Momentum A VGM
Zacks News
Best Value Stocks to Buy for July 25th
by Zacks Equity Research
MOV, SEM and JACK made it to the Zacks Rank #1 (Strong Buy) value stocks list on July 25, 2023.
Select Medical (SEM) Expects Q2 Adjusted EBITDA to Jump 21% Y/Y
by Zacks Equity Research
Select Medical's (SEM) strong second-quarter 2023 guidance highlights improving performance in all four segments.
Select Medical (SEM) Up 21% Year to Date: More Room to Run?
by Zacks Equity Research
Select Medical (SEM) is well-poised for growth on the back of improved patient volumes, an expanding healthcare portfolio and solid cash-generating abilities.
Company News for Jul 5, 2023
by Zacks Equity Research
Companies in The News Are: WFC, SEM, RIVN, TSLA, MRVL
The Joint Corp. (JYNT) Surges 10.0%: Is This an Indication of Further Gains?
by Zacks Equity Research
The Joint Corp. (JYNT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Select Medical (SEM) Q1 Earnings Top on Improving Profitability
by Zacks Equity Research
Select Medical (SEM) expects revenues to be within the range of $6.5-$6.7 billion in 2023, indicating a rise of 4.8% from the 2022 figure of $6.3 billion.
Select Medical (SEM) Q1 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of 51.35% and 3.01%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Reports Next Week: What to Know Ahead of the Release
by Zacks Equity Research
Select Medical (SEM) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina (MOH) Q1 Earnings Beat Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 13.26% and 1.04%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Misses Q1 Earnings Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of -5.38% and 7.11%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Buys Richmond Post-Acute Care Facility
by Zacks Equity Research
Select Medical (SEM) acquires the Vibra Hospital of Richmond to provide enhanced critical illness recovery care across Virginia.
Select Medical's (SEM) Orlando Facility to Boost Post-Acute Care
by Zacks Equity Research
Select Medical (SEM) aims to address the post-acute care demand in the Central Florida region through the construction of a specialty hospital in Orlando.
Select Medical (SEM) Forays Into Indiana With Lutheran Health JV
by Zacks Equity Research
Select Medical (SEM) partners with Lutheran Health Network to enhance critical illness recovery and inpatient rehabilitation services in Fort Wayne and neighborhood communities.
Select Medical (SEM) Q4 Earnings Miss Estimates, Revenues Up
by Zacks Equity Research
Select Medical (SEM) anticipates 2023 revenues to be within $6.5-$6.7 billion.
Select Medical (SEM) Misses Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of -33.33% and 2.35%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) to Post Q4 Earnings: What to Expect
by Zacks Equity Research
Select Medical's (SEM) fourth-quarter results are likely to reflect improved figures in the Rehabilitation Hospital business.
Select Medical (SEM) Enters JV to Boost New Jersey Healthcare
by Zacks Equity Research
Select Medical (SEM) collaborates with AtlantiCare to open an inpatient rehabilitation hospital and jointly manage the operations of SEM's outpatient centers across New Jersey.
Select Medical (SEM) Shares Fall 9.6% Since Q3 Earnings Miss
by Zacks Equity Research
Select Medical (SEM) reports improved performance in the Rehabilitation Hospital unit for the third quarter.
Select Medical (SEM) Q3 Earnings Miss Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of -52.27% and 1.14%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Humana (HUM) Tops Q3 Earnings Estimates
by Zacks Equity Research
Humana (HUM) delivered earnings and revenue surprises of 10.08% and 0.02%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Centene (CNC) Tops Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Centene (CNC) delivered earnings and revenue surprises of 6.56% and 1.08%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Select Medical (SEM) Plans 3rd Hospital in Central Pennsylvania
by Zacks Equity Research
Select Medical (SEM) joins forces with UPMC to open its third inpatient rehabilitation hospital in Central Pennsylvania to better address the region's post-acute care needs.
Select Medical (SEM) Shares Dip on Q2 Earnings & Revenue Miss
by Zacks Equity Research
Select Medical's (SEM) second-quarter earnings take a hit from escalating expenses and reduced admissions within the Critical Illness Recovery Hospital segment.
Select Medical (SEM) Misses Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Select Medical (SEM) delivered earnings and revenue surprises of -15.69% and 1.71%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?
Molina (MOH) Tops Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Molina (MOH) delivered earnings and revenue surprises of 4.84% and 6.21%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?